Table 2.
Differences in clinical outcomes between study groups at baseline (N = 299).
| Outcome measures | Control group Mean ± SD |
Intervention group | Value of p* |
|---|---|---|---|
| FBS (mmol/L) | 14.63 ± 1.37 | 14.51 ± 1.47 | 0.451 |
| RBS (mmol/L) | 17.60 ± 1.14 | 17.86 ± 1.12 | 0.056 |
| HbA1c (%) | 11.30 ± 1.18 | 11.41 ± 1.10 | 0.427 |
| BP systolic (mmHg) | 137.54 ± 4.47 | 139.26 ± 5.39 | 0.008 |
| BP diastolic (mmHg) | 86.66 ± 5.50 | 87.21 ± 5.77 | 0.403 |
| T. Cholesterol (mmol/L) | 6.03 ± 0.34 | 6.16 ± 0.35 | 0.002 |
| Triglyceride (mmol/L) | 2.01 ± 0.18 | 2.06 ± 0.21 | 0.026 |
| LDL-C (mmol/L) | 2.81 ± 0.17 | 3.87 ± 0.29 | 0.001 |
| HDL-C (mmol/L) | 1.04 ± 0.26 | 1.00 ± 0.26 | 0.002 |
*Two-way ANOVA test.